A robust, well thought out response, the keyelements of which are:
- PNC followed due process indetermining what they believe to be the correct accounting treatment under AASB9
- PNC has kept the appropriate partiesinformed at all times
- PWC has initially agreed to theaccounting treatment to be used (December 2017)
In my view PWC are probably re-thinking thevalidity of the approach, given that some of PNC’s competitors are using adifferent accounting treatment. If theybelieve that there is no difference between PNC’s asset (PDPs) and similar typeassets held by other industry players then PWC are not going to be keen to buckthe trend by signing-off on a different accounting treatment.
In order to retain their position I believePNC will have to provide a compelling case that their asset is completelydifferent to that of their competitors.
PNC have put forward a strong case, butthat’s no guarantee they will win the argument. However, the big unknown, if they lose, is what amortisation would do tothe bottom line (all three scenarios: up, down and no change, appear possible).
Interesting times ahead
- Forums
- ASX - By Stock
- PNC
- Ann: Response to ASX Query - Half Year Accounts
PNC
pioneer credit limited
Add to My Watchlist
0.00%
!
51.0¢

Ann: Response to ASX Query - Half Year Accounts, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
51.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $81.96M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 0.500 |
2 | 20657 | 0.480 |
1 | 21250 | 0.470 |
1 | 10000 | 0.460 |
1 | 22000 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.535 | 3324 | 1 |
0.540 | 4645 | 1 |
0.585 | 10000 | 1 |
0.600 | 11966 | 2 |
0.610 | 16395 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
PNC (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online